The odd phenomenon of quantum superposition has helped researchers break a fundamental quantum mechanical limit – and given quantum objects properties that make them useful for quantum computing for ...

Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech on track to start a pivotal study next year. The Californian company’s ...

Pioneers like Thermo Fisher, Axos Bank, and Ascot Insurance have more than 5,500 AI agents in development, delivering measurable efficiency gains and optimizing workflows "The enterprise AI race isn’t ...

Global One Conference, the annual event of low-code stalwarts OutSystems, begins with customer stories and then, as new Chief Executive Officer (CEO) Woodson Martin takes the stage, he continues to ...

Abstract: Depression is a serious mental disorder with complex etiology, exhibiting strong heterogeneity in clinical manifestations such as various subtypes. Research on depression subtypes may deepen ...

Dozens of porn sites are turning to a familiar source to generate likes on Facebook—malware that causes browsers to surreptitiously endorse the sites. This time, the sites are using a newer vehicle ...

Converting utf8 encoded strings to Js strings is one of the biggest performance overheads we have when interacting between the FFI host context and the JavaScript context. In the scenario where we ...

Welcome to Tool Tip Tuesday for Adobe Premiere Pro on ProVideo Coalition. Every week, we will share a new tooltip to save time when working in Adobe Premiere Pro. If you send files to Adobe Media ...

Low-Code Application Platforms (LCAPs) have been around in some form since the early 2000s, though the term "low-code" itself wasn't popularized until around 2014. The industry analysts at Forrester ...

Encoded Therapeutics is shrinking its headcount by 29% as the gene therapy biotech draws resources away from its early-stage R&D toward its Dravet syndrome program. The asset in question, dubbed ...

Encoded’s layoffs will mostly affect its technology and early-stage research and development functions. The move is expected to keep the biotech operational well into 2026. To extend its cash runway ...